Effect of Salmonella typhi wild type and O-antigen mutants on human natural killer cell activity

International Journal of Immunopharmacology

Volumn 22, Issue 5, 2000, Pages 355-364

  Puente, Javier ^a   Blanco, Luz ^a   Montoya, Margarita ^a   Miranda, Dante ^a   Contreras, Inés ^a   Vinés, Enrique ^a   Wolf, Marion E ^b   Mosnaim, Aron D ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c 3333 Gn Bay Road   (United States)

Author keywords

Bacterial lipopolysaccharide (LPS); Gram negative bacteria; Highly purified natural killer (HPNK) cell; Monocyte released cytokines; Natural killer (NK) cell activity; Peripheral blood mononuclear cells (PBMC); S. typhi Ty2 wild type and O antigen mutants

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD16 ANTIGEN; CD56 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR; MONOKINE; O ANTIGEN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOPHENOTYPING; MALE; MONONUCLEAR CELL; MUTANT; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; SALMONELLA TYPHI; STRAIN DIFFERENCE;

ADULT; CYTOKINES; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; O ANTIGENS; SALMONELLA TYPHI;

EID: 0034191930     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00089-2     Document Type: Article

References (44)

1. Bermúdez L.E., Kolonoski P., Young L.S. Natural killer cell activity and macrophage dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model. J. Leukoc. Biol. 47:1990;135-142.
2. Bermúdez L.E., Young L.S. Natural killer cell dependent mycobacteriostatic and mycobactericidal activity in human macrophages. J. Immunol. 146:1991;265-269.
3. Bermúdez L.E., Wu M., Young L.S. Interleukin-12-stimulated natural killer cells can activate macrophages to inhibit the growth of Mycobacterium avium. Infect. Immun. 63:1995;4099-4104.
4. Blanchard K.D., Stewart W.E. II, Klein T.W., Friedman H., Djeu J.Y. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J. Immunol. 139:1987;551-556.
5. Blanchard K.D., Michelin-Norris B.M., Friedman H., Djeu J.Y. Lysis of Mycobacteria infected monocytes by IL-12 activated killer cells: role of LFA-1. Cell. Immunol. 119:1989;402-411.
6. Blanchard D.M., Michelini-Norris M.B., Djeu J.Y. Production of granulocyte macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. Blood. 77:1991;2259-2265.
7. Blanchard K.D., McMillen S., Hoffman S.L., Djeu J.Y. Mycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin-2 receptor alpha expression. Infect. Immun. 60:1992;2843-2849.
8. Borrego F., Peña J., Solana R. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases. Eur. J. Immunol. 23:1993;1039-1043.
9. Contreras I., Obreque V., Tesser B., Mora G.C. Mini-Mu technology in Salmonella typhi: isolation of stable MudJ operon fusions by cic complementation. Biol. Res. 27:1994;233-239.
10. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., Cowdery J.S. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84:1997;185-193.
11. Chatfield S.N., Li J.L., Sydenham M., Douce G., Dougan G. Salmonella genetics and vaccine development. Hormaeche C., Penn C.W., Smyth C.J. Molecular biology of bacterial infection: current status and future perspectives. Soc. Gen. Microbiol. Symposium. 49:1992;300-312 Cambridge University Press, United Kingdom.
12. Fiorentino D., Zlotnik A., Mosmann T., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
13. Flesch I., Kaufmann S.H.S. Mycobacterial growth inhibition by interferon-g-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 138:1987;4408-4413.
14. García-Peñarrubia P., Koster T., Kelley R.O., McDowell T.D., Bankhurst A.D. Antibacterial activity of human natural killer cells. J. Exp. Med. 169:1989;99-113.
15. Gebran S.J., Yamamoto Y., Newton C., Klein T.W., Friedman H. Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron (III). Infect. Immun. 62:1994;3197-3205.
16. Grim E.A., Mazumder A., Zhang H., Rosenberg S. Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin-2-activated autologous generation of lymphokine-activated killer cells. J. Exp. Med. 155:1982;823-830.
17. Hitchcock P.J., Brown T.M. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrilamide gels. J. Bacteriol. 154:1983;269-277.
18. Janeway C.A. Jr, Travers P. Host defense against infection. Robertson M., Ward R., Lawrence E., Palmer R., Dorey E. Immunobiology: the immune system in health and disease. 1994;Current Biology, Garland, Blackwell, London, United Kingdom.
19. Kagaya K., Wantanabe K., Fukazawa Y. Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity. Infect. Immun. 57:1989;609-615.
20. Kaufmann S.H.E. Immunity to intracellular bacteria. Annual Rev. Immunol. 11:1993;29-63.
21. Kundu N., Fulton A. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis. Cell. Immunol. 180:1997;55-61.
22. Lanier L.L., Buck D.W., Rhodes L., Ding A., Evans E., Barney C., Phillips J.H. Interleukin-2 activation of human natural killer cells rapidly induces the expression and phosphorylation of the Leu23 activation antigen. J. Exp. Med. 167:1988;1572-1585.
23. Lindemann R.A. Bacterial activation of human natural killer cells: role of cell surface lipopolysaccharide. Infect. Immun. 56:1998;1301-1308.
24. Mroczenski-Wildey M.J., DiFabio J.L., Cabello F.C. Invasion and lysis of HeLa cell monolayers by Salmonella typhi: the role of lipopolysaccharide. Microbial. Patholog. 6:1989;143-152.
25. Miranda D., Puente J., Blanco L., Wolf M.E., Mosnaim A.D. In vitro effect of bacterial lipopolysaccharide on the cytotoxicity of human natural killer cells. Res. Commun. Mol. Pathol. Pharmacol. 100:1998;3-14.
26. Murphy J., Zhou A., Wong S.S. Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. Infect. Immun. 65:1997;4564-4571.
27. + NK cells. J. Immunol. 148:1992;2429-2436.
28. Nencioni L., Villa L., Boraschi D., Berti B., Tagliabue A. Natural and antibody dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice. J. Immunol. 130:1983;903-907.
29. Park J., Rikihisa Y. Inhibition of Ehrlichia risticii infection in murine peritoneal macrophages by gamma interferon, a calcium ionophore, and concanavalin A. Infect. Immun. 59:1991;3418-3423.
30. Puente J., Carvajal T., Parra S., Miranda D., Sepúlveda C., Wolf M.E., Mosnaim A.D. In vitro studies of natural killer cell activity in septic shock patients. Int. J. Clin. Pharmacol. Therap. Toxicol. 31:1993;271-275.
31. Puente J., Carvajal T., Parra S., Miranda D., Sepúlveda C., Wolf M.E., Mosnaim A.D. Enhancement of natural killer cell activity in septic shock patients by a mixture of the calcium ionophore A23187 and the phorbol ester TPA: in vitro studies. Int. J. Clin. Pharmacol. Therapy. 43:1994;19-23.
32. Rietchel F.T., Kirikae T., Schade U.F., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zahringer U., Seydel U., DiPadova F., Schreier M., Brade H. Bacterial endotoxin molecular relationships of structure to activity and function. FASEB J. 8:1994;217-225.
33. Robertson M.J., Ritz J. Biology and clinical relevance of human natural killer cells. Blood. 76:1990;2421-2438.
34. Schagger H., Von Jagow G. Tricine-sodium dodecyl sulfate-polyacrilamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
35. Sepúlveda C., Puente J., Weinstein C., Wolf M.E., Mosnaim A.D. Enhancement of natural killer cell activity in HIV-1-infected subjects by a mixture of the calcium ionophore A23187 and the phorphol ester TPA: lack of response to a similar challenge with interleukin-2 and a-interferon. Am. J. Therap. 4:1997;413-421.
36. Sibley D.L., Franzblau S.G., Krahenbuhl J.L. Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages. Infect. Immun. 55:1987;680-685.
37. Tarkkanen J., Saksela E., Lanier L.L. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell. J. Immunol. 137:1986;2428-2433.
38. Tarkkanen J., Saxén H., Nurminen M., Mäkelä H.P., Saksela E. Bacterial induction of human activated lymphocyte killing and its inhibition by lipopolysaccharide (LPS). J. Immunol. 136:1986;2662-2669.
39. Tarkkanen J., Saksela E. Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase. Infect. Immun. 59:1991;2767-2773.
40. Tarkkanen J., Kosunen T.U., Saksela E. Contact of lymphocytes with Helicobacter pylori auguments natural killer cell activity and induces production of gamma interferon. Infect. Immun. 61:1993;3012-3016.
41. Tsai C.M., Frasch C.E. A sensitive silver stain for detecting lipopolysaccharides in polyacrilamide gels. Anal. Biochem. 119:1982;115-119.
42. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-375.
43. Werfel T., Boeker M., Kapp A. Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions. Allergy. 52:1997;465-469.
44. Yoshihara R., Shioznan S., Fujita T., Chihara K. Gamma interferon is produced by human natural killer cells but not T cells during Staphylococcus aureous stimulation. Infect. Immun. 61:1993;3117-3122.